Skip to main content
. 2021 Apr 6;13(7):1744. doi: 10.3390/cancers13071744

Table 2.

Cellular stress response upregulated by mEHT treatment. Genes (official name abbreviations as used in all multiplex platforms and descriptions of the coded proteins) detected as upregulated with all three multiplex methods (NGS RNA Seq, Nanostring, MS) are designated with bold letters. Nanostring validated all NGS hits with a similar FC value. Hspa1a and Hspa1b are the most common isoforms of Hsp70. Cell line: 4T1, 3× treated.

Nr. Gene Name Description NGS Nanostring MS
FC p FC p LFQ Intensity Difference p
Protease inhibitors
1 Itih2 inter-alpha trypsin inhibitor. heavy chain 2 31.1 2.1 × 10−5 * 2.9 7.7 × 10−5
2 Itih4 inter alpha-trypsin inhibitor. heavy chain 4 22.7 2.7 × 10−4 9.5 0.005 2.5 6.1 × 10−5
3 Serpina3n serine (or cysteine) peptidase inhibitor. clade A. member 3N 8.4 6.8 × 10−4 8.1 9.11 × 10−5 3.2 6.1 × 10−4
4 Serpina3c serine (or cysteine) peptidase inhibitor. clade A. member 3C 7.0 0.011 5.3 5.0 × 10−4 Not detected Not detected
5 Serpina3m serine (or cysteine) peptidase inhibitor. clade A. member 3M 6.4 0.001 6.2 6.1 × 10−5 0.1 0.891
Coagulation factors
6 Fgb fibrinogen beta chain 28.4 2.1 × 10−4 * 2.4 5.2 × 10−6
7 Fgg fibrinogen gamma chain 15.0 0.006 14.2 0.003 2.1 3.8 × 10−5
8 Hp haptoglobin 9.7 7.4 × 10−4 7.5 2.5 × 10−4 4.7 8.3 × 10−4
Complement factors
9 Ptx3 pentraxin related gene 5.6 0.046 10.1 7.5 × 10−4 Not detected Not detected
10 Cfd complement factor D (adipsin) 10.0 0.001 7.8 8.8 × 10−4 2.0 0.001
11 C4b complement component 4B (Chido blood group) 4.6 0.03 4.8 0.001 3.1 2.9 × 10−4
12 Hc hemolytic complement 3.9 0.04 1.9 0.335 1.2 1.7 × 10−4
13 C1s1 complement component 1. s subcomponent 1 3.4 0.049 3.3 0.002 Not detected Not detected
Heat shock factors
Hspb1 Heat shock protein beta-1 3.8 0.075 not investigated 2.7 1.1 × 10−5
Hspa1a Heat shock 70 kDa protein 1A 2.0 0.551 not investigated 2.1 1.3 × 10−5
Hspa1b Heat shock 70 kDa protein 1B 2.4 0.362
Hsph1 Heat shock protein 105 kDa 1.8 0.761 not investigated 1.3 0.023

* uniquely expressed in mEHT-treated samples but not in the sham-treated tumors, no FC applies by the nanostring evaluation.